These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 21332723)
1. A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia. Kroll H; Feldmann K; Zwingel C; Hoch J; Bald R; Bein G; Bayat B; Santoso S Transfusion; 2011 Aug; 51(8):1745-54. PubMed ID: 21332723 [TBL] [Abstract][Full Text] [Related]
2. The new platelet alloantigen Cab a: a single point mutation Gln 716 His on the alpha 2 integrin. Bertrand G; Jallu V; Saillant D; Kervran D; Martageix C; Kaplan C Transfusion; 2009 Oct; 49(10):2076-83. PubMed ID: 19500323 [TBL] [Abstract][Full Text] [Related]
3. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens. Kroll H; Yates J; Santoso S Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152 [TBL] [Abstract][Full Text] [Related]
4. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia. Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Socher I; Zwingel C; Santoso S; Kroll H Transfusion; 2008 Mar; 48(3):463-72. PubMed ID: 18067506 [TBL] [Abstract][Full Text] [Related]
7. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia. Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334 [TBL] [Abstract][Full Text] [Related]
8. A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia. Poles A; Woźniak MJ; Walser P; Ridgwell K; Fitzgerald J; Green A; Gilmore R; Lucas G Transfusion; 2013 Sep; 53(9):1965-73. PubMed ID: 23305224 [TBL] [Abstract][Full Text] [Related]
9. A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation. Santoso S; Amrhein J; Hofmann HA; Sachs UJ; Walka MM; Kroll H; Kiefel V Blood; 1999 Dec; 94(12):4103-11. PubMed ID: 10590055 [TBL] [Abstract][Full Text] [Related]
10. Cab4b, the first human platelet antigen carried by glycoprotein IX discovered in a context of severe neonatal thrombocytopenia. Jallu V; Beranger T; Bianchi F; Casale C; Chenet C; Ferre N; Philippe S; Quesne J; Martageix C; Petermann R J Thromb Haemost; 2017 Aug; 15(8):1646-1654. PubMed ID: 28561420 [TBL] [Abstract][Full Text] [Related]
11. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia. Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382 [TBL] [Abstract][Full Text] [Related]
13. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227 [TBL] [Abstract][Full Text] [Related]
14. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229 [TBL] [Abstract][Full Text] [Related]
15. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia. Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia. Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia. de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048 [TBL] [Abstract][Full Text] [Related]
18. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia. Salomon O; Rosenberg N Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281 [TBL] [Abstract][Full Text] [Related]
19. Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a. Kroll H; Penke G; Santoso S Thromb Haemost; 2005 Dec; 94(6):1224-9. PubMed ID: 16411398 [TBL] [Abstract][Full Text] [Related]
20. Further observations on the clinical significance and inheritance of the low-frequency platelet antigen HPA-28bw. Lucas G; Poles A; Woźniak MJ; Gilmore R Transfusion; 2016 Apr; 56(4):873-7. PubMed ID: 26645993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]